Talk to sales Try for Free
Daniel DeZeery, MD

Daniel DeZeery, MD

English Language Teacher

Followers of Daniel DeZeery, MD277 followers
location of Daniel DeZeery, MDRiverside, California, United States

Connect with Daniel DeZeery, MD to Send Message

Connect

Connect with Daniel DeZeery, MD to Send Message

Connect

  • Timeline

  • About me

    Resident Physician

  • Education

    • University of Debrecen

      2015 - 2022
      Doctor of Medicine - MD Medicine 4.4 GPA (5-point scale)

      Activities and Societies: - Hungarian Society of Cardiology - Cardio-Oncology researcher - Student’s Scientific Association - University Rugby team (DEAC) - Volunteer for the International Student Union (ISU) - Ambassador for the North American Student Association (NASA)

  • Experience

    • Italki

      Jan 2020 - Feb 2022
      English Language Teacher

      Taught english as a second language using the iTalki platform.

    • University of Debrecen Medical School

      Jun 2021 - Jun 2022
      Sub-intern

      Rotated at the 6 major departments (internal medicine, surgery, OBGYN, neurology, psychiatry, pediatrics) at the Debrecen University Hospital.

    • Corewell Health

      Oct 2022 - May 2023
      Medical Scribe

      Documenting using Epic EMR in the emergency department of Beaumont Grosse Pointe.

    • Arrowhead Regional Medical Center

      Jul 2023 - now
      Internal Medicine Resident

      ACC member, Quality improvement committee, board member for the San Bernardino County Medical Society, cardio-oncology research, case studies, mentorship program for CUSM medical students, 96th percentile nationally on ABIM ITE

  • Licenses & Certifications

    • Educational Commission for Foreign Medical Graduates (ECFMG)

      Intealth
      Dec 2022

  • Honors & Awards

    • Awarded to Daniel DeZeery, MD
      Cum laude - Jun 2022 Graduated in the top 20% of the class of 2022.
    • Awarded to Daniel DeZeery, MD
      Honorary Award Students Scientific Associated Feb 2022 For work titled “Assessing cardiotoxic side effects related to the oral and intravenous forms of fluoropyrimidines by continuous ECG monitoring” presented at the Local SSA conference in Debrecen, Hungary in 2022.